Company Filing History:
Years Active: 2016-2018
Title: Daigen Xu: Innovator in Interleukin-10 Fusion Proteins
Introduction
Daigen Xu is a notable inventor based in North Caldwell, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins that have potential therapeutic applications.
Latest Patents
Daigen Xu holds 2 patents related to interleukin-10 fusion proteins. His latest patents focus on the creation of fusion proteins that combine antibodies with interleukin-10 (IL-10). These inventions also encompass polynucleotides that encode such fusion proteins, as well as vectors and host cells that contain these polynucleotides. The methods for producing these fusion proteins and their applications in treating diseases are also covered in his patents.
Career Highlights
Daigen Xu is currently associated with Roche Glycart AG, where he continues to advance his research in the field of biotechnology. His work is pivotal in exploring new therapeutic avenues for various diseases through innovative protein engineering.
Collaborations
Some of his notable coworkers include Lydia Jasmin Duerner and Thomas Emrich, who contribute to the collaborative efforts in their research endeavors.
Conclusion
Daigen Xu's work in interleukin-10 fusion proteins exemplifies the innovative spirit of modern biotechnology. His contributions are paving the way for new treatments that could significantly impact patient care.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.